Dr. Sangeeta S. Nadkarni, MD

Dr. Nadkarni practices at Fresenius Medical Care Merrimack Valley in Tewksbury, Massachusetts.

Dr. Nadkarni's NPI, 1245332667, was assigned on September 5, 2006. Dr. Nadkarni holds Massachusetts license 226820.

Dr. Nadkarni's primary practice is Fresenius Medical Care Merrimack Valley, at 600 Clark Rd, Tewksbury, MA 01876 in Middlesex County. The practice phone is (978) 686-9900.

Dr. Nadkarni's primary practice is Fresenius Medical Care Merrimack Valley in Tewksbury, Massachusetts. Dr. Nadkarni is also affiliated with Salem Hospital. The medical group on file is Mass General Brigham (formerly North Shore Physicians Group). Dmand AI also links Dr. Nadkarni to 4 more hospitals, 3 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nadkarni practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Nadkarni's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Nadkarni is licensed in Massachusetts.

CMS data shows 1,114 Medicare services from Dr. Nadkarni across 12 procedure codes in 2024, for 406 Medicare patients. Medicare paid $143,087 for them.

CMS counts 406 Medicare patients who saw Dr. Nadkarni in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 46% are also on Medicaid. Their average risk score is 3.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nadkarni's median patient age at 72, with 48% women.

In 2024, Dr. Nadkarni wrote 1,830 Medicare Part D claims for 364 patients. 82% of them were for generic drugs. CMS names the drug for 1,659 of them, across 26 drugs with 11 or more claims each, at $340,887 in total drug cost. In 2023, CMS named 1,184 claims across 18 drugs.

Dr. Nadkarni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nadkarni as offering telehealth.

CMS Open Payments shows 29 general payments to Dr. Nadkarni from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bausch Health Americas, Inc. paid the most, $88.